Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More
doctor_and_patient

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More
people_walking

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More
elder_women

BeiGene News

November 27, 2024

European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer

Read more

November 26, 2024

BeiGene to Present at Upcoming Investor Conferences

Read more

November 19, 2024

BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA

Read more

November 14, 2024

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

Read more

November 12, 2024

BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates

Read more

November 6, 2024

BeiGene to Present at the Jefferies London Healthcare Conference

Read more